Cecilia Furlong
Stock Analyst at Morgan Stanley
(1.88)
# 2,848
Out of 4,818 analysts
168
Total ratings
42.86%
Success rate
-2.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Cecilia Furlong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Upgrades: Overweight | $522 → $650 | $487.93 | +33.22% | 13 | Dec 2, 2024 | |
| SGHT Sight Sciences | Maintains: Equal-Weight | $7 → $5 | $3.21 | +55.76% | 15 | Nov 11, 2024 | |
| EMBC Embecta | Maintains: Underweight | $13 → $12 | $11.26 | +6.62% | 12 | Jul 15, 2024 | |
| IRTC iRhythm Technologies | Maintains: Overweight | $135 → $130 | $102.93 | +26.31% | 15 | Jul 15, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Equal-Weight | $130 → $120 | $99.54 | +20.55% | 11 | Jul 15, 2024 | |
| TMDX TransMedics Group | Maintains: Equal-Weight | $75 → $95 | $92.25 | +2.98% | 12 | Feb 28, 2024 | |
| MDT Medtronic | Maintains: Overweight | $104 → $98 | $83.72 | +17.06% | 9 | Nov 22, 2023 | |
| ALC Alcon | Maintains: Equal-Weight | $78 → $85 | $93.73 | -9.31% | 9 | May 11, 2023 | |
| AORT Artivion | Maintains: Equal-Weight | $14 → $15 | $23.77 | -36.90% | 4 | May 8, 2023 | |
| PODD Insulet | Maintains: Equal-Weight | $325 → $343 | $246.79 | +38.98% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $11 → $14 | $4.98 | +181.12% | 7 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $44 → $48 | $29.65 | +61.89% | 4 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $95 → $102 | $70.46 | +44.76% | 8 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $56 → $58 | $98.87 | -41.34% | 17 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $20 | $12.78 | +56.56% | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $117 → $131 | $67.25 | +94.80% | 7 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $133 | $129.82 | +2.45% | 11 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $270 → $220 | $357.11 | -38.39% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $383 → $378 | $133.00 | +184.21% | 2 | Feb 25, 2022 |
Intuitive Surgical
Dec 2, 2024
Upgrades: Overweight
Price Target: $522 → $650
Current: $487.93
Upside: +33.22%
Sight Sciences
Nov 11, 2024
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.21
Upside: +55.76%
Embecta
Jul 15, 2024
Maintains: Underweight
Price Target: $13 → $12
Current: $11.26
Upside: +6.62%
iRhythm Technologies
Jul 15, 2024
Maintains: Overweight
Price Target: $135 → $130
Current: $102.93
Upside: +26.31%
Zimmer Biomet Holdings
Jul 15, 2024
Maintains: Equal-Weight
Price Target: $130 → $120
Current: $99.54
Upside: +20.55%
TransMedics Group
Feb 28, 2024
Maintains: Equal-Weight
Price Target: $75 → $95
Current: $92.25
Upside: +2.98%
Medtronic
Nov 22, 2023
Maintains: Overweight
Price Target: $104 → $98
Current: $83.72
Upside: +17.06%
Alcon
May 11, 2023
Maintains: Equal-Weight
Price Target: $78 → $85
Current: $93.73
Upside: -9.31%
Artivion
May 8, 2023
Maintains: Equal-Weight
Price Target: $14 → $15
Current: $23.77
Upside: -36.90%
Insulet
May 5, 2023
Maintains: Equal-Weight
Price Target: $325 → $343
Current: $246.79
Upside: +38.98%
May 3, 2023
Maintains: Equal-Weight
Price Target: $11 → $14
Current: $4.98
Upside: +181.12%
Apr 28, 2023
Maintains: Equal-Weight
Price Target: $44 → $48
Current: $29.65
Upside: +61.89%
Apr 27, 2023
Maintains: Overweight
Price Target: $95 → $102
Current: $70.46
Upside: +44.76%
Apr 27, 2023
Maintains: Overweight
Price Target: $56 → $58
Current: $98.87
Upside: -41.34%
Feb 23, 2023
Maintains: Equal-Weight
Price Target: $18 → $20
Current: $12.78
Upside: +56.56%
Jan 6, 2023
Maintains: Equal-Weight
Price Target: $117 → $131
Current: $67.25
Upside: +94.80%
Jan 6, 2023
Maintains: Overweight
Price Target: $117 → $133
Current: $129.82
Upside: +2.45%
Jul 15, 2022
Maintains: Equal-Weight
Price Target: $270 → $220
Current: $357.11
Upside: -38.39%
Feb 25, 2022
Maintains: Equal-Weight
Price Target: $383 → $378
Current: $133.00
Upside: +184.21%